Cargando…
The potential role of Colchicine in preventing coronary vascular disease in childhood‐onset lupus: a new view on an old drug
BACKGROUND: Patients with systemic lupus erythematous have a significantly increased risk of cardiovascular disease, which is not fully explained by traditional cardiovascular disease risk factors. Despite increasing life expectancy in patients with systemic lupus erythematous, mortality due to card...
Autores principales: | Abel, Dori, Ardoin, Stacy P., Gorelik, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885423/ https://www.ncbi.nlm.nih.gov/pubmed/33593369 http://dx.doi.org/10.1186/s12969-021-00504-6 |
Ejemplares similares
-
Research priorities in childhood-onset lupus: results of a multidisciplinary prioritization exercise
por: Ardoin, Stacy P., et al.
Publicado: (2019) -
Colchicine—regeneration of an old drug
por: Casey, Aoife, et al.
Publicado: (2022) -
Developing consensus treatment plans for proliferative lupus nephritis in childhood-onset systemic lupus erythematous
por: Mina, Rina, et al.
Publicado: (2012) -
Developments in the scientific understanding of lupus
por: Ardoin, Stacy P, et al.
Publicado: (2008) -
Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE
por: Gilbert, Mileka, et al.
Publicado: (2021)